Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2019 08:00 ET | Source: BrainsWay Ltd.

BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder

JERUSALEM, Jan. 29, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN), a global leader in the advanced non-invasive treatment of brain disorders, today announced that its Deep TMS System has been...
December 10, 2018 07:00 ET | Source: BrainsWay Ltd.

BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder

HACKENSACK, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN), the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain...
November 13, 2018 08:00 ET | Source: BrainsWay Ltd.

Brainsway Reports Financial Results for Third Quarter of 2018 and Provides Corporate Update

Third quarter revenues of $4.3 million represent quarterly record and 42% increase over third quarter 2017 Recently commenced installing Deep TMS system for treatment of OCD at U.S. Sites ...
October 17, 2018 08:00 ET | Source: BrainsWay Ltd.

BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 Annual Psych Congress

Showcase represents the public debut of BrainsWay’s Deep TMS system for OCD Healthcare providers will be able to view demonstrations of and purchase the BrainsWay system and OCD helmet at conference...
October 08, 2018 08:00 ET | Source: BrainsWay Ltd.

BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder

Twenty sites across the U.S. are the first to receive the BrainsWay Deep transcranial magnetic stimulation system (Deep TMS) for obsessive-compulsive disorder (OCD) HACKENSACK, N.J., Oct. 08, 2018 ...
August 27, 2018 08:00 ET | Source: Brainsway Ltd.

Brainsway Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update

Second quarter revenues of $3.7 million represent a quarterly record and a 57% increase over second quarter 2017 Recently announced FDA clearance of Deep TMS system for treatment of OCD expected to...
August 20, 2018 08:00 ET | Source: Brainsway Ltd.

BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive-Compulsive Disorder

BrainsWay’s deep transcranial magnetic stimulation (Deep TMS) system is a best-in-class device designed to maximize electromagnetic stimulation of deep and broad brain regions, helping to launch a new...
July 10, 2018 09:00 ET | Source: Brainsway Ltd.

Sandhya Prashad, M.D., Now Offering BrainsWay Deep TMS to Patients With Depression in Houston Area

BELLAIRE, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- Houston psychiatrist Sandhya Prashad, M.D., today announced that her practice is now offering BrainsWay Deep Transcranial Magnetic Stimulation...
June 07, 2018 08:15 ET | Source: Brainsway Ltd.

Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder

Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress Disorder (PTSD) HACKENSACK, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Brainsway Ltd....
May 29, 2018 07:00 ET | Source: Brainsway Ltd.

Brainsway Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update

First quarter revenues of $3.6 million represent a quarterly record and a 68% increase over first quarter 2017 Increased market demand and leasing model continue to generate sales growth ...